We are live on ! Find out more
EW icon

Edwards Lifesciences

1,083 hedge funds and large institutions have $41.1B invested in Edwards Lifesciences in 2020 Q3 according to their latest regulatory filings, with 108 funds opening new positions, 396 increasing their positions, 374 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $221M | Put options by funds: $152M

39% more capital inflows, than outflows

Capital inflows: $2.77B | Capital outflows: $1.99B

36% more funds holding in top 10

Funds holding in top 10: 14 → 19 (+5)

35% more first-time investments, than exits

New positions opened: 108 | Existing positions closed: 80

3% more funds holding

Funds holding: 1,047 → 1,083 (+36)

1.13% more ownership

Funds ownership: 81.63% → 82.76% (+1.1%)

6% more repeat investments, than reductions

Existing positions increased: 396 | Existing positions reduced: 374

Holders
1,083
Holders Change
+36
Holders Change %
+3.44%
% of All Funds
21.79%
Holding in Top 10
19
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+35.71%
% of All Funds
0.38%
New
108
Increased
396
Reduced
374
Closed
80
Calls
$221​M
Puts
$152​M
Net Calls
+$69​M
Net Calls Change
+$52.7​M

EW Hedge Fund Activity: Q3 2020 in Review

1,083 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q3 2020, worth a combined $41.1B — up 17% from $35B a quarter earlier.

Buyers outnumbered sellers: 108 funds opened new EW positions and 80 closed out — a net gain of 28 holders — while 396 added to existing stakes and 374 trimmed.

The largest buyer was Jackson Square Partners, opening a new position worth an estimated $469M. The largest seller was Two Sigma Advisers, cutting an estimated $142M.

  • 1,083 institutional investors held Edwards Lifesciences (EW) as of Q3 2020, up from 1,047 in Q2 2020.
  • Funds reported $41.1B of Edwards Lifesciences stock for Q3 2020, up 17% quarter-over-quarter.
  • 108 funds opened new Edwards Lifesciences positions in Q3 2020 and 80 closed out, a net change of +28 holders.
  • The largest Edwards Lifesciences buyer in Q3 2020 was Jackson Square Partners, an estimated $469M added.
  • The largest Edwards Lifesciences seller in Q3 2020 was Two Sigma Advisers, an estimated $142M sold.

Based on aggregated 13F filings for Q3 2020.